COCH Latest Press Releases

-- December 18, 2025 --

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant Newsfile 8:01 AM

-- December 16, 2025 --

Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio Newsfile 8:01 AM

-- December 10, 2025 --

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant Newsfile 8:00 AM

-- December 4, 2025 --

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient Newsfile 8:00 AM

-- December 2, 2025 --

Envoy Medical Announces the Grant of Its 40th U.S. Patent Newsfile 8:01 AM

-- November 20, 2025 --

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery Newsfile 8:00 AM

-- November 18, 2025 --

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial Newsfile 8:01 AM

-- November 10, 2025 --

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results Newsfile 8:01 AM

-- November 4, 2025 --

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial Newsfile 8:01 AM

-- October 29, 2025 --

AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing Globe Newswire 8:35 AM

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant Newsfile 8:01 AM

-- October 27, 2025 --

Envoy Medical Receives Positive Listing Determination from NASDAQ Newsfile 8:00 AM

-- October 23, 2025 --

AI & Technology Virtual Investor Conference Agenda Announced for October 28th Globe Newswire 3:24 PM

Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th Globe Newswire 8:00 AM

-- October 9, 2025 --

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Newsfile 4:05 PM

-- October 8, 2025 --

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Newsfile 7:00 AM

-- October 7, 2025 --

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data Newsfile 9:15 AM

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data Newsfile 9:14 AM

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data Newsfile 8:00 AM

-- October 1, 2025 --

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th Newsfile 8:00 AM

-- September 25, 2025 --

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Newsfile 8:00 AM

-- September 24, 2025 --

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track Newsfile 8:00 AM

-- September 22, 2025 --

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Newsfile 8:00 AM

-- September 19, 2025 --

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology Newsfile 8:00 AM

-- September 10, 2025 --

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments Newsfile 8:00 AM

-- September 9, 2025 --

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology Newsfile 8:00 AM

-- September 8, 2025 --

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025 Newsfile 8:00 AM

-- September 3, 2025 --

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant Newsfile 8:00 AM

-- August 26, 2025 --

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board Newsfile 8:00 AM

-- August 20, 2025 --

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology Newsfile 8:00 AM